AMGN

Amgen Inc. Common Stock

Nasdaq Global Select

$227.5

Open: $232.63 High: $234.65 Low: $227 Close: $227.5

Range: 2022-01-20 - 2022-01-21

Volume:4,508,331

Market: Closed

Get Free API Key

Download as Excel

AMGN

Amgen Inc. Common Stock One Amgen Center Drive Thousand Oaks CA, 91320-1799 http://www.amgen.com

Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human therapeutics.

CEO: Robert A. Bradway
Employees: 20,800
Sector: Healthcare
Industry: Biotechnology

Latest Stocks Posts

View All Posts >

AMGN News

Latest news about the AMGN

3 Healthcare Stocks With High Dividends
Looking for a healthcare stock that will pay you to own it? Here are three suggestions.
by The Motley Fool at 1/21/22, 12:00 AMView More →
1 Top Dividend Stock to Buy and Hold in 2022 and Beyond
This year should be better than last year for healthcare giant Amgen.
by The Motley Fool at 1/13/22, 12:00 AMView More →
My 3 Top Biotech Stock Picks for 2022
These stocks are poised for a strong year.
by The Motley Fool at 1/9/22, 12:00 AMView More →
7 Pharmaceutical Stocks That Could Make You Rich
These seven pharmaceutical stocks could create lucrative opportunities in the new year
by Investor Place at 1/6/22, 12:00 AMView More →
What Does This Label Expansion Mean for Amgen's Shareholders?
The U.S. Food and Drug Administration recently approved Amgen's Otezla to treat all severity levels of plaque psoriasis.
by The Motley Fool at 1/5/22, 12:00 AMView More →
BAD ETF: The Top "Sin Stock" Holdings in the New Anti-ESG Fund That Debuts Today
There's a new ETF on the block from BAD Investment Company and it seeks to offer investments in sin stocks for interested traders.
by Investor Place at 12/22/21, 12:00 AMView More →
U.S. FDA approves expanded use of Amgen's psoriasis drug
The U.S. Food and Drug Administration has approved the expanded use of Amgen Inc's drug Otezla to treat adults with mild to moderate plaque psoriasis, the drugmaker said on Monday.
by Reuters at 12/20/21, 9:42 PMView More →
FDA approves expanded use of Amgen's psoriasis drug
The U.S. Food and Drug Administration has approved the expanded use of Amgen Inc's drug Otezla to treat adults with mild to moderate plaque psoriasis, the drugmaker said on Monday.
by Reuters at 12/20/21, 9:30 PMView More →
U.S. FDA approves AstraZeneca-Amgen drug for severe asthma
The U.S. Food and Drug Administration approved AstraZeneca and Amgen's drug, Tezspire, to treat severe asthma for those aged 12 years and older, the companies said on Friday.
by Reuters at 12/17/21, 11:19 PMView More →
7 Drug Stocks to Buy Now While They're Still on Sale
Covid-19 stocks soared to unsustainable highs as investors ignored drug stocks with a deep pipeline of products for the decade ahead.
by Investor Place at 11/30/21, 12:00 AMView More →

S&P 500

NASDAQ 100

FTSE 100

QQQ

TESLA

BTC/USD

GBP/USD

GOLD